Home › Triple-Negative Breast Cancer › Texas › Dallas

Pag-aaral pangklinika para sa Triple-Negative Breast Cancer sa Dallas, TX

Isang pag-aaral para sa Triple-Negative Breast Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Nagre-recruitPhase 1/2

UT Southwest Simmons Cancer Center, Dallas

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1

UT Southwestern, Dallas

Edad 19 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06586957

Study of AVZO-021 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Avenzo Therapeutics Recruiting Site, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05867251

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Nagre-recruitPhase 3

Texas Oncology - DFW ( Site 8007), Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06841354

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Nagre-recruitPhase 3

Texas Oncology - DFW ( Site 8000), Dallas
Parkland Health & Hospital System ( Site 0096), Dallas
University of Texas Southwestern Medical Center ( Site 0032), Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06393374

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Nagre-recruitPhase 3

Texas Oncology - DFW ( Site 8009), Dallas
UT Southwestern ( Site 0092), Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06966700

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1

University of Texas Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07029399

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Nagre-recruitPhase 1

Normunity Investigational Site, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07182149

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Nagre-recruitPhase 1/2

Mary Crowley Cancer Research, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Nagre-recruitPhase 1

University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
UT Southwestern Medical Center - Redbird, Dallas
Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
at 2 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT05208762

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Nagre-recruitPhase 1/2

Texas Oncology, P.A., Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT05377996

Study of XB010 in Subjects With Solid Tumors

Nagre-recruitPhase 1

Baylor University Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT06545331

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1

Baylor University Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT05768932

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

Nagre-recruitPhase 1/2

Texas Oncology - DFW, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 30, 2026 · NCT06926920

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Mary Crowley Cancer Research, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 9, 2026 · NCT05490472

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Nagre-recruitPhase 1

Dren Investigational Site, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 7, 2026 · NCT06999187

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

Nagre-recruitMaagang Phase 1

Baylor University Medical Center, Baylor Charles A Sammons Cancer Center, Dallas

Edad 18 pataas · Kababaihan · Na-update Nob 10, 2025 · NCT06008275

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1

NEXT Oncology, Dallas, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 26, 2024 · NCT05746897

Pag-aaral para sa Triple-Negative Breast Cancer sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.